News

High-level briefing: Regional merger scrapped | Provider chain denied | Holiday inspiration appreciated | more

The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.

FDA approves new drug for genetic heart disease

Cytokinetics has secured FDA approval for aficamten, its new drug for the treatment of symptomatic obstructive HCM. Aficamten will be sold under the brand name Myqorzo.

A diabetic foot ulcer that does not heal due to low blood supply from peripheral artery disease (PAD), and the before and after interventional angiograms of the patient's revascularization treatment. Images courtesy of Foluso Fakorede, MD

ACC calls for better management of peripheral artery disease in diabetic patients

PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

SCAI town hall addresses workforce concerns in interventional cardiology

One of the event's primary takeaways was that interventional cardiology does still attract a healthy number of trainees. However, SCAI sees several ways the specialty can improve to be even more appealing in the future.

heart data research doctor cardiologist AI

New PFA registry will use AI, EHR integration to gather real-world data

PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.

Cardiology’s biggest trend: New scientific statements take on AI-powered coronary plaque evaluations

The ACC and AHA both issued new statements on noninvasive CCTA offerings that use advanced AI to evaluate patients with suspected CAD. These technologies have gained significant momentum in recent years, and experts agree that they represent a game-changing advancement in the world of cardiovascular imaging.

Judge rejects radiologist’s attempt to revive lawsuit alleging age bias led to her termination

The case dates to July 2019, when breast specialist Claire Hanley, MD, first filed suit against New York City Health and Hospitals Corp.

Anthem defends controversial policy penalizing hospitals who use out-of-network radiologists

Rads and other physicians have roundly criticized the change, labeling the policy as “deeply flawed and operationally unworkable.”

Morgue manager at Harvard Medical School gets 8 years for selling the deceased

Cedric Lodge, 58, pleaded guilty in May for his role in procuring human organs and tissue for sale on an interstate black market. His wife, Denise Lodge, was sentenced to one year for collaborating. The couple sold organs out of their home in New Hampshire, prosecutors said.

New data on GBCA safety indicate risk of renal complications 'exceedingly low'

Nephrogenic systemic fibrosis is a serious, potentially fatal disease that progressively causes the skin and underlying tissues to harden.

Leading nuclear medicine organizations collaborate to streamline PET accreditation

The groups have jointly endorsed a unified framework “to standardize and harmonize quantitative PET imaging worldwide.”

business marketing meal lunch food group project team building

TAVR or SAVR? Market competition may be influencing these decisions

Hospitals located in more competitive markets may be more likely to perform TAVR instead of SAVR, according to a new analysis of more than 130,000 patients. Is this a reason for concern?

Around the web

Health Exec